Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 4,193 | 20,538 | 17,355 | 16,413 | 18,263 |
| Operating Income | -4,193 | -20,538 | -17,355 | -16,413 | -18,263 |
| Interest Expense | 1,409 | 0 | 0 | 0 | 0 |
| Other Income | -567 | 6,169 | -7,940 | 7,106 | 3,879 |
| Pre-tax Income | -6,169 | -14,369 | -25,295 | -9,307 | -14,385 |
| Net Income Continuous | -6,169 | -14,369 | -25,295 | -9,307 | -14,385 |
| Net Income | $-6,169 | $-14,369 | $-25,295 | $-9,307 | $-14,385 |
| EPS Basic Total Ops | -2.17 | -21.00 | -44.18 | -20.65 | -37.94 |
| EPS Basic Continuous Ops | -2.17 | -20.98 | -44.34 | -20.55 | -37.87 |
| EPS Diluted Total Ops | -2.17 | -21.00 | -44.18 | -20.65 | -37.94 |
| EPS Diluted Continuous Ops | -2.17 | -20.98 | -44.34 | -20.55 | -37.87 |
| EBITDA(a) | $-4,190 | $-20,825 | $-17,348 | $-16,446 | $-18,293 |